# Plain Language Summary: Protecting America from Seasonal and Pandemic Influenza Act of 2023

This bill is about getting the country better prepared for flu outbreaks and potential flu pandemics. It sets specific goals and funding to improve how quickly we can develop and deliver flu vaccines, create better treatments, and improve testing. The bill recognizes that regular seasonal flu kills thousands of Americans every year and costs the economy hundreds of billions of dollars, while a major flu pandemic could be catastrophic. It also notes that minority communities have been hit harder by flu hospitalizations, so the bill emphasizes making sure improvements reach everyone fairly.

The bill creates two major national goals. First, within three years, the government should be able to deliver the first doses of a new flu vaccine within 12 weeks of a dangerous new flu strain emerging—right now this takes much longer. Second, within ten years, the country should develop a "universal" flu vaccine that works against many different flu strains, so people wouldn't need a new shot every year. To make this happen, the bill dedicates $335 million per year through 2028 to research, development, and stockpiling of vaccines, treatments, and testing supplies.

The bill also focuses on strengthening the supply chain for vaccines and related equipment like needles and syringes by creating partnerships between government and private companies. It directs the government to study how emergency powers (like the Defense Production Act) could be used to boost domestic manufacturing capacity during a flu emergency. Additionally, the bill pushes for better diagnostic testing, including at-home tests that people can use themselves, and supports research into new antiviral treatments and monoclonal antibodies that could treat flu more effectively.

Finally, the bill addresses vaccine hesitancy and misinformation by supporting better communication and outreach about vaccines and treatments, particularly in communities that have been underserved or are skeptical of vaccines. The goal is to make sure that when new vaccines and treatments become available, people actually use them and that improvements benefit all Americans, not just some.